drugset / Trial / NCT04806854
PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)
RandomizedParallel-groupOpen-labelTreatment
Summary
The goals of this single site trial are to study the pharmacokinetics (PK) and pharmacodynamics of LUM-201 and effects of LUM-201 administration on growth hormone release over time in children with idiopathic pediatric growth hormone deficiency (PGHD).
Timeline
- Start
- 2021-07-14
- Primary completion
- 2030-04
- Completion
- 2030-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LUM-201 | Unknown | 1.6 mg/kg | Oral |
| Subject | LUM-201 | Unknown | 3.2 mg/kg | Oral |